ProKidney Corp. (PROK)
| Previous close | 2.4000 |
| Open | 2.3200 |
| Bid | 2.0100 x 100 |
| Ask | 2.5400 x 200 |
| Day's range | 1.9700 - 2.4500 |
| 52-week range | 1.1200 - 13.5100 |
| Volume | |
| Avg. volume | 661,208 |
| Market cap | 1.529B |
| Beta (5Y monthly) | 1.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
In this article, we discuss Chamath Palihapitiya and the 12 stocks he pumped in the last 10 years. If you want to read about some more Chamath Palihapitiya stocks, go directly to Chamath Palihapitiya Stocks: 5 Stocks Pumped in the Last 10 Years. Chamath Palihapitiya is an investing genius, even though some of his opinions […]
- Zacks
Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now
ProKidney Corp. (PROK) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- Insider Monkey
ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript
ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript November 16, 2023 Operator: Good morning, ladies and gentlemen, and welcome to the ProKidney Corporate Update Conference Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded. […]
